LIPOPLUS

This brand name is authorized in Ecuador, Spain, Finland

Active ingredients

The drug LIPOPLUS contains a combination of these active pharmaceutical ingredients (APIs):

1 Triglycerides, medium chain UNII C9H2L21V7U - MEDIUM-CHAIN TRIGLYCERIDES

Read about Triglycerides, medium chain

2 Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL

Read about Soybean oil, refined

3 Omega-3-acid ethyl esters UNII 71M78END5S - OMEGA-3 FATTY ACIDS

Read about Omega-3-acid ethyl esters

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B05BA	Solutions for parenteral nutrition	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions
Discover more medicines within B05BA
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H4170413
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 66708
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 020725